sprite-preloader
Dienstag, 26.05.2015 Börsentäglich über 12.000 News von 513 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen
12.04.2013 | 14:04
(105 Leser)
Schrift ändern:
(0 Bewertungen)

PR Newswire·Mehr Nachrichten von PR Newswire

LONDON, April 12, 2013 /PRNewswire/ --

The Supreme Court, last year, upheld President Obama's Affordable Care Act (ACA), which is the biggest overhaul of the healthcare sector in decades. The ACA is expected to increase the number of insured individuals, which will benefit the sector. However, the reform is also expected to increase costs for the healthcare sector. Perhaps the biggest impact of the ACA in the near-term will be felt by medical instruments & supplies companies such as Antares Pharma Inc. (NASDAQ: ATRS) as they are required to pay a tax on gross sales. The ACA will also have a significant impact on medical laboratories & research companies such as Life Technologies Corp. (NASDAQ: LIFE), and Quest Diagnostics Inc. (NYSE: DGX), long-term care facilities providers such as Brookdale Senior Living Inc. (NYSE: BKD), and biotechnologies companies such as Optimer Pharmaceuticals Inc. (NASDAQ: OPTR). Healthcare stocks ended mostly higher on Thursday, tracking gains in the broad market. StockCall has posted free technical research on LIFE, DGX, BKD, ATRS, and OPTR which can be downloaded upon sign up at

http://www.stockcall.com/signup

Life Technologies Corp.'s shares edged higher yesterday. The stock closed 0.35% higher at $66.81 on above average volume of 3.58 million. Shares of LIFE have gained more than 2.20% in the last three trading sessions. The stock is currently trading close to its 52-week high of $67.92. Year-to-date, the stock has gained more than 36%, outperforming the broad market. Sign up and read the complimentary report on LIFE at

http://www.StockCall.com/LIFE041213.pdf

Shares of Quest Diagnostics Inc. rallied in trading on Thursday. The stock closed 4.42% higher at $59.83 on above average volume of 3.20 million. It also touched an intra-day high of $60 yesterday. Quest Diagnostics' shares have gained more than 5.60% in the last two sessions. The two-day rally has pushed the stock above its 50-day and 200-day moving averages, which is a bullish signal. The free report on DGX can be downloaded by signing up now at

http://www.StockCall.com/DGX041213.pdf

Shares of Brookdale Senior Living Inc. rose sharply yesterday, ending the day 2.21% higher at $28.20 on above average volume of 952,129. The stock touched an intra-day high of $28.33 in Thursday's session. The Long-Term Care Facility's shares have just moved above their 50-day moving average, which is a bullish signal. The upbeat trend is further confirmed by the stock's MACD chart. Free report on BKD can be accessed by registering at

http://www.StockCall.com/BKD041213.pdf

Shares of Antares Pharma Inc. edged higher in Thursday's session, extending its gains from the previous two trading sessions. The stock closed 1.42% higher at $3.57 on above average volume of 999,964, taking its gains in the last three sessions to nearly 3.50%. Despite the recent gains, Antares Pharma's shares have fallen 6.30% so far in 2013. The stock is currently trading more than 36% below its 52-week high. Register with StockCall and download the research on ATRS for free at

http://www.StockCall.com/ATRS041213.pdf

Shares of Optimer Pharmaceuticals Inc. rose in trading yesterday; however, the gains were limited. The stock closed 0.34% higher at $14.83 on volume of 429,780. The biotech company's shares have had an excellent run so far in 2013, gaining nearly 64%. The stock is currently trading well above its 50-day and 200-day moving averages. Read the full free research on OPTR by signing up to StockCall at

http://www.StockCall.com/OPTR041213.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at

http://www.stockcall.com

SOURCE StockCall.com


© 2013 PR Newswire